Heidi Health
The Product Manager for Scribe at Heidi is responsible for shaping and owning the core clinical documentation experience used by hundreds of thousands of clinicians globally. This role involves collaborating closely with engineering, design, and clinical teams to enhance user experience through meaningful feature developments, while maintaining a focus on quality and reliability. The ideal candidate will have extensive experience delivering consumer-grade software at scale, a deep understanding of clinician workflows, and strong communication skills across various teams, all aimed at improving healthcare systems through innovative technology.
Headquarters
Melbourne, Victoria, Australia
Company Size
11-50 employees
Founded
2019
Heidi Health is an AI-powered care partner designed for modern clinical practice, offering tools that support clinicians across documentation, evidence lookup, and patient communications. Their products — including an AI scribe and a wearable mic called Heidi Remote — are designed to reduce administrative burden and save clinicians time. Heidi serves a wide range of specialties and healthcare systems globally, with a strong focus on safety, privacy, and clinical accuracy.
Heidi Health raises $65M to expand global reach of its AI medical scribe platform
Oct 6, 2025
Heidi Health Secures $65M to Scale AI Care Partner Platform Globally
Oct 7, 2025
Here's the pitch deck that Point72-backed Heidi Health used to raise $65 million to battle in the AI scribe race
Oct 8, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Heidi Health.
Heidi Health didn’t post a salary, so this is our estimate from similar listings.
Heidi Health raises $65M Series B led by Steve Cohen’s Point72 Private Investments
Oct 5, 2025